메뉴 건너뛰기




Volumn 12, Issue 9, 2013, Pages 688-702

Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

Author keywords

[No Author keywords available]

Indexed keywords

2 ACETYL 4 TETRAHYDROXYBUTYLIMIDAZOLE; 2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; 2 AMINO 2 [2 [4 (3 BENZYLOXYPHENYLTHIO) 2 CHLOROPHENYL]ETHYL] 1,3 PROPANEDIOL; 3 [2 (3 TRIFLUOROMETHYL 4 BIPHENYLYL)BENZO[B]THIEN 5 YLMETHYLAMINO]PROPIONIC ACID; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ABC 294640; ALKANOLAMINE; BAF 312; CISPLATIN; CS 0777; CYM 5442; ENZYME INHIBITOR; FENRETINIDE; FINGOLIMOD; GSK 2018682; LX 2931; LX 3305; ONO 4641; PONESIMOD; RPC 1063; SAFINGOL; SIPONIMOD; SONEPCIZUMAB; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; TASP 0277308; UNCLASSIFIED DRUG; UNINDEXED DRUG; VPC 44116; W 146;

EID: 84883455835     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4099     Document Type: Review
Times cited : (381)

References (142)
  • 1
    • 0026049696 scopus 로고
    • Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation
    • Zhang, H. et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114, 155-167 (1991).
    • (1991) J. Cell Biol , vol.114 , pp. 155-167
    • Zhang, H.1
  • 2
    • 77953790503 scopus 로고    scopus 로고
    • An update on sphingosine-1-phosphate and other sphingolipid mediators
    • Fyrst, H. & Saba, J. D. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nature Chem. Biol. 6, 489-497 (2010).
    • (2010) Nature Chem. Biol , vol.6 , pp. 489-497
    • Fyrst, H.1    Saba, J.D.2
  • 3
    • 79961082952 scopus 로고    scopus 로고
    • Translational aspects of sphingosine 1-phosphate biology
    • Pyne, S. & Pyne, N. J. Translational aspects of sphingosine 1-phosphate biology. Trends Mol. Med. 17, 463-472 (2011).
    • (2011) Trends Mol. Med , vol.17 , pp. 463-472
    • Pyne, S.1    Pyne, N.J.2
  • 4
    • 84868517918 scopus 로고    scopus 로고
    • Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: Review of sphingosine kinase inhibitors
    • Orr Gandy, K. A. & Obeid, L. M. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim. Biophys. Acta 1831, 157-166 (2013).
    • (2013) Biochim. Biophys. Acta , vol.1831 , pp. 157-166
    • Orr Gandy, K.A.1    Obeid, L.M.2
  • 6
    • 84878906549 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate and its receptors: Structure, signaling, and influence
    • Rosen, H., Stevens, R. C., Hanson, M., Roberts, E. & Oldstone, M. B. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu. Rev. Biochem. 82, 637-662 (2013).
    • (2013) Annu. Rev. Biochem , vol.82 , pp. 637-662
    • Rosen, H.1    Stevens, R.C.2    Hanson, M.3    Roberts, E.4    Oldstone, M.B.5
  • 7
    • 77953966511 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate and cancer
    • Pyne, N. J. & Pyne, S. Sphingosine 1-phosphate and cancer. Nature Rev. Cancer 10, 489-503 (2010).
    • (2010) Nature Rev. Cancer , vol.10 , pp. 489-503
    • Pyne, N.J.1    Pyne, S.2
  • 8
    • 79957610938 scopus 로고    scopus 로고
    • The outs and the ins of sphingosine-1-phosphate in immunity
    • Spiegel, S. & Milstien, S. The outs and the ins of sphingosine-1-phosphate in immunity. Nature Rev. Immunol. 11, 403-415 (2011).
    • (2011) Nature Rev. Immunol , vol.11 , pp. 403-415
    • Spiegel, S.1    Milstien, S.2
  • 9
    • 84859385704 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs
    • Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94 (2012).
    • (2012) Annu. Rev. Immunol , vol.30 , pp. 69-94
    • Cyster, J.G.1    Schwab, S.R.2
  • 10
    • 0029948396 scopus 로고    scopus 로고
    • Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
    • Cuvillier, O. et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803 (1996).
    • (1996) Nature , vol.381 , pp. 800-803
    • Cuvillier, O.1
  • 11
    • 78049480679 scopus 로고    scopus 로고
    • Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis
    • Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature Rev. Drug Discov. 9, 883-897 (2010).
    • (2010) Nature Rev. Drug Discov , vol.9 , pp. 883-897
    • Brinkmann, V.1
  • 12
    • 77953923379 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
    • Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088 (2010).
    • (2010) Nature , vol.465 , pp. 1084-1088
    • Alvarez, S.E.1
  • 13
    • 69949113620 scopus 로고    scopus 로고
    • Regulation of histone acetylation in the nucleus by sphingosine-1- phosphate
    • Hait, N. C. et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254-1257 (2009).
    • (2009) Science , vol.325 , pp. 1254-1257
    • Hait, N.C.1
  • 14
    • 79955770841 scopus 로고    scopus 로고
    • BACE1 activity is modulated by cell-associated sphingosine-1-phosphate
    • Takasugi, N. et al. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J. Neurosci. 31, 6850-6857 (2011).
    • (2011) J. Neurosci , vol.31 , pp. 6850-6857
    • Takasugi, N.1
  • 16
    • 58849083220 scopus 로고    scopus 로고
    • The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors
    • Kawahara, A. et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 323, 524-527 (2009).
    • (2009) Science , vol.323 , pp. 524-527
    • Kawahara, A.1
  • 17
    • 84874599020 scopus 로고    scopus 로고
    • Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network
    • Nagahashi, M. et al. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. FASEB J. 27, 1001-1011 (2013).
    • (2013) FASEB J , vol.27 , pp. 1001-1011
    • Nagahashi, M.1
  • 18
    • 84862188843 scopus 로고    scopus 로고
    • Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells
    • Hisano, Y., Kobayashi, N., Yamaguchi, A. & Nishi, T. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS ONE 7, e38941 (2012).
    • (2012) PLoS ONE , vol.7
    • Hisano, Y.1    Kobayashi, N.2    Yamaguchi, A.3    Nishi, T.4
  • 19
    • 84859727262 scopus 로고    scopus 로고
    • The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice
    • Fukuhara, S. et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 122, 1416-1426 (2012).
    • (2012) J. Clin. Invest , vol.122 , pp. 1416-1426
    • Fukuhara, S.1
  • 20
    • 84870432809 scopus 로고    scopus 로고
    • The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate
    • Mendoza, A. et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep. 2, 1104-1110 (2012).
    • (2012) Cell Rep , vol.2 , pp. 1104-1110
    • Mendoza, A.1
  • 21
    • 79958257954 scopus 로고    scopus 로고
    • Lipid phosphate phosphatase 3 enables efficient thymic egress
    • Breart, B. et al. Lipid phosphate phosphatase 3 enables efficient thymic egress. J. Exp. Med. 208, 1267-1278 (2011).
    • (2011) J. Exp. Med , vol.208 , pp. 1267-1278
    • Breart, B.1
  • 22
    • 84872406787 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer
    • Liang, J. et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107-120 (2013).
    • (2013) Cancer Cell , vol.23 , pp. 107-120
    • Liang, J.1
  • 23
    • 28544437478 scopus 로고    scopus 로고
    • Essential role for sphingosine kinases in neural and vascular development
    • Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 11113-11121 (2005).
    • (2005) Mol. Cell. Biol , vol.25 , pp. 11113-11121
    • Mizugishi, K.1
  • 24
    • 38549152194 scopus 로고    scopus 로고
    • Principles of bioactive lipid signalling: Lessons from sphingolipids
    • Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Rev. Mol. Cell. Biol. 9, 139-150 (2008).
    • (2008) Nature Rev. Mol. Cell. Biol , vol.9 , pp. 139-150
    • Hannun, Y.A.1    Obeid, L.M.2
  • 25
    • 78649982367 scopus 로고    scopus 로고
    • STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
    • Lee, H. et al. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nature Med. 16, 1421-1428 (2010).
    • (2010) Nature Med , vol.16 , pp. 1421-1428
    • Lee, H.1
  • 26
    • 84865159639 scopus 로고    scopus 로고
    • S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma
    • Liu, Y. et al. S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood 120, 1458-1465 (2012).
    • (2012) Blood , vol.120 , pp. 1458-1465
    • Liu, Y.1
  • 27
    • 84861399789 scopus 로고    scopus 로고
    • S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites
    • Deng, J. et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 21, 642-654 (2012).
    • (2012) Cancer Cell , vol.21 , pp. 642-654
    • Deng, J.1
  • 28
    • 84863057277 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by tumor-induced angiogenesis and lymphangiogenesis
    • Nagahashi, M. et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by tumor-induced angiogenesis and lymphangiogenesis. Cancer Res. 72, 726-735 (2012).
    • (2012) Cancer Res , vol.72 , pp. 726-735
    • Nagahashi, M.1
  • 29
    • 84864797320 scopus 로고    scopus 로고
    • Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis
    • Ponnusamy, S. et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol. Med. 4, 761-775 (2012).
    • (2012) EMBO Mol. Med , vol.4 , pp. 761-775
    • Ponnusamy, S.1
  • 30
    • 52949143502 scopus 로고    scopus 로고
    • Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
    • Ruckhaberle, E. et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 112, 41-52 (2008).
    • (2008) Breast Cancer Res. Treat , vol.112 , pp. 41-52
    • Ruckhaberle, E.1
  • 31
    • 59649086217 scopus 로고    scopus 로고
    • Role for sphingosine kinase 1 in colon carcinogenesis
    • Kawamori, T. et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405-414 (2008).
    • (2008) FASEB J , vol.23 , pp. 405-414
    • Kawamori, T.1
  • 32
    • 84888279260 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate receptors and sphingosine kinase 1: Novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
    • Pyne, S., Edwards, J., Ohotski, J. & Pyne, N. J. Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers. Front. Oncol. 2, 168 (2012).
    • (2012) Front. Oncol , vol.2 , pp. 168
    • Pyne, S.1    Edwards, J.2    Ohotski, J.3    Pyne, N.J.4
  • 33
    • 51649122574 scopus 로고    scopus 로고
    • A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
    • Paugh, S. W. et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 112, 1382-1391 (2008).
    • (2008) Blood , vol.112 , pp. 1382-1391
    • Paugh, S.W.1
  • 34
    • 82455192466 scopus 로고    scopus 로고
    • Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
    • Kharel, Y. et al. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem. J. 440, 345-353 (2011).
    • (2011) Biochem. J , vol.440 , pp. 345-353
    • Kharel, Y.1
  • 35
    • 84860812174 scopus 로고    scopus 로고
    • Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1
    • Schnute, M. E. et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem. J. 444, 79-88 (2012).
    • (2012) Biochem. J , vol.444 , pp. 79-88
    • Schnute, M.E.1
  • 36
    • 80155127315 scopus 로고    scopus 로고
    • Sphingosine kinase inhibitors and cancer: Seeking the golden sword of Hercules
    • Pyne, S., Bittman, R. & Pyne, N. J. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res. 71, 6576-6582 (2011).
    • (2011) Cancer Res , vol.71 , pp. 6576-6582
    • Pyne, S.1    Bittman, R.2    Pyne, N.J.3
  • 37
    • 84877253249 scopus 로고    scopus 로고
    • Molecular basis of sphingosine kinase 1 substrate recognition and catalysis
    • Wang, Z. et al. Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. Structure 21, 798-809 (2013).
    • (2013) Structure , vol.21 , pp. 798-809
    • Wang, Z.1
  • 38
    • 84857873334 scopus 로고    scopus 로고
    • Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis
    • Chipuk, J. E. et al. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148, 988-1000 (2012).
    • (2012) Cell , vol.148 , pp. 988-1000
    • Chipuk, J.E.1
  • 39
    • 84856745167 scopus 로고    scopus 로고
    • A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection
    • Gomez, L. et al. A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Bas. Res. Cardiol. 106, 1341-1353 (2011).
    • (2011) Bas. Res. Cardiol , vol.106 , pp. 1341-1353
    • Gomez, L.1
  • 40
    • 79955068081 scopus 로고    scopus 로고
    • A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning
    • Vessey, D. A. et al. A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid. Med. Cell. Longev. 2011, 961059 (2011).
    • (2011) Oxid. Med. Cell. Longev , pp. 961059
    • Vessey, D.A.1
  • 41
    • 79551648970 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration
    • Strub, G. M. et al. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25, 600-612 (2011).
    • (2011) FASEB J , vol.25 , pp. 600-612
    • Strub, G.M.1
  • 42
    • 77949748845 scopus 로고    scopus 로고
    • Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2
    • French, K. J. et al. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J. Pharmacol. Exp. Ther. 333, 129-139 (2010).
    • (2010) J. Pharmacol. Exp. Ther , vol.333 , pp. 129-139
    • French, K.J.1
  • 43
    • 78049490720 scopus 로고    scopus 로고
    • Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640
    • Antoon, J. W. et al. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology 151, 5124-5135 (2010).
    • (2010) Endocrinology , vol.151 , pp. 5124-5135
    • Antoon, J.W.1
  • 44
    • 84866379271 scopus 로고    scopus 로고
    • Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate
    • Kharel, Y. et al. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Biochem. J. 447, 149-157 (2012).
    • (2012) Biochem. J , vol.447 , pp. 149-157
    • Kharel, Y.1
  • 45
    • 38449084602 scopus 로고    scopus 로고
    • Cutting edge: Modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate
    • Samy, E. T. et al. Cutting edge: modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. J. Immunol. 179, 5644-5648 (2007).
    • (2007) J. Immunol , vol.179 , pp. 5644-5648
    • Samy, E.T.1
  • 47
    • 77957770455 scopus 로고    scopus 로고
    • Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase
    • Chumanevich, A. A. et al. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Carcinogenesis 31, 1787-1793 (2010).
    • (2010) Carcinogenesis , vol.31 , pp. 1787-1793
    • Chumanevich, A.A.1
  • 48
    • 77956894066 scopus 로고    scopus 로고
    • Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis
    • Baker, D. A., Barth, J., Chang, R., Obeid, L. M. & Gilkeson, G. S. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. J. Immunol. 185, 2570-2579 (2010).
    • (2010) J. Immunol , vol.185 , pp. 2570-2579
    • Baker, D.A.1    Barth, J.2    Chang, R.3    Obeid, L.M.4    Gilkeson, G.S.5
  • 49
    • 79958190513 scopus 로고    scopus 로고
    • Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase
    • Fitzpatrick, L. R. et al. Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase. Inflammopharmacology 19, 75-87 (2011).
    • (2011) Inflammopharmacology , vol.19 , pp. 75-87
    • Fitzpatrick, L.R.1
  • 50
    • 53249130741 scopus 로고    scopus 로고
    • Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
    • Kazantsev, A. G. & Thompson, L. M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nature Rev. Drug Discov. 7, 854-868 (2008).
    • (2008) Nature Rev. Drug Discov , vol.7 , pp. 854-868
    • Kazantsev, A.G.1    Thompson, L.M.2
  • 51
    • 57749170458 scopus 로고    scopus 로고
    • The many roles of histone deacetylases in development and physiology: Implications for disease and therapy
    • Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Rev. Genet. 10, 32-42 (2009).
    • (2009) Nature Rev. Genet , vol.10 , pp. 32-42
    • Haberland, M.1    Montgomery, R.L.2    Olson, E.N.3
  • 53
    • 84861430003 scopus 로고    scopus 로고
    • The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway
    • Nakahara, K. et al. The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. Mol. Cell 46, 461-471 (2012).
    • (2012) Mol. Cell , vol.46 , pp. 461-471
    • Nakahara, K.1
  • 54
    • 84861003638 scopus 로고    scopus 로고
    • Truth and consequences of sphingosine-1-phosphate lyase
    • Aguilar, A. & Saba, J. D. Truth and consequences of sphingosine-1-phosphate lyase. Adv. Biol. Regul. 52, 17-30 (2012).
    • (2012) Adv. Biol. Regul , vol.52 , pp. 17-30
    • Aguilar, A.1    Saba, J.D.2
  • 55
    • 84867277218 scopus 로고    scopus 로고
    • Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts
    • Ihlefeld, K., Claas, R. F., Koch, A., Pfeilschifter, J. M. & Meyer Zu Heringdorf, D. Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. Biochem. J. 447, 457-464 (2012).
    • (2012) Biochem. J , vol.447 , pp. 457-464
    • Ihlefeld, K.1    Claas, R.F.2    Koch, A.3    Pfeilschifter, J.M.4    Meyer Zu Heringdorf, D.5
  • 56
    • 24644469502 scopus 로고    scopus 로고
    • Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
    • Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735-1739 (2005).
    • (2005) Science , vol.309 , pp. 1735-1739
    • Schwab, S.R.1
  • 57
    • 78650381368 scopus 로고    scopus 로고
    • Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4- tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)
    • Bagdanoff, J. T. et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3, 4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). J. Med. Chem. 53, 8650-8662 (2010).
    • (2010) J. Med. Chem , vol.53 , pp. 8650-8662
    • Bagdanoff, J.T.1
  • 58
    • 77955508596 scopus 로고    scopus 로고
    • Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism
    • Bourquin, F., Riezman, H., Capitani, G. & Grutter, M. G. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. Structure 18, 1054-1065 (2010).
    • (2010) Structure , vol.18 , pp. 1054-1065
    • Bourquin, F.1    Riezman, H.2    Capitani, G.3    Grutter, M.G.4
  • 59
    • 33746075255 scopus 로고    scopus 로고
    • Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling
    • Nagata, Y., Partridge, T. A., Matsuda, R. & Zammit, P. S. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol. 174, 245-253 (2006).
    • (2006) J. Cell Biol , vol.174 , pp. 245-253
    • Nagata, Y.1    Partridge, T.A.2    Matsuda, R.3    Zammit, P.S.4
  • 60
    • 84861014560 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway
    • Loh, K. C. et al. Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS ONE 7, e37218 (2012).
    • (2012) PLoS ONE , vol.7
    • Loh, K.C.1
  • 61
    • 84870661131 scopus 로고    scopus 로고
    • Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila
    • Pantoja, M., Fischer, K. A., Ieronimakis, N., Reyes, M. & Ruohola-Baker, H. Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. Development 140, 136-146 (2013).
    • (2013) Development , vol.140 , pp. 136-146
    • Pantoja, M.1    Fischer, K.A.2    Ieronimakis, N.3    Reyes, M.4    Ruohola-Baker, H.5
  • 62
    • 84857254248 scopus 로고    scopus 로고
    • Crystal structure of a lipid G protein-coupled receptor
    • Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851-855 (2012).
    • (2012) Science , vol.335 , pp. 851-855
    • Hanson, M.A.1
  • 63
    • 0037066466 scopus 로고    scopus 로고
    • Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
    • Mandala, S. et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349 (2002).
    • (2002) Science , vol.296 , pp. 346-349
    • Mandala, S.1
  • 64
    • 0037077308 scopus 로고    scopus 로고
    • The immune modulator, FTY720, targets sphingosine 1-phosphate receptors
    • Brinkmann, V. et al. The immune modulator, FTY720, targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457 (2002).
    • (2002) J. Biol. Chem , vol.277 , pp. 21453-21457
    • Brinkmann, V.1
  • 65
    • 2442679391 scopus 로고    scopus 로고
    • The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors
    • Graler, M. H. & Goetzl, E. J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J. 18, 551-553 (2004).
    • (2004) FASEB J , vol.18 , pp. 551-553
    • Graler, M.H.1    Goetzl, E.J.2
  • 66
    • 84856073375 scopus 로고    scopus 로고
    • S1P1 receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis
    • Gonzalez-Cabrera, P. J. et al. S1P1 receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis. Mol. Pharmacol. 81, 166-174 (2012).
    • (2012) Mol. Pharmacol , vol.81 , pp. 166-174
    • Gonzalez-Cabrera, P.J.1
  • 67
    • 34648832173 scopus 로고    scopus 로고
    • FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
    • Neviani, P. et al. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J. Clin. Invest. 117, 2408-2421 (2007).
    • (2007) J. Clin. Invest , vol.117 , pp. 2408-2421
    • Neviani, P.1
  • 68
    • 84867319781 scopus 로고    scopus 로고
    • The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: Translation from preclinical to clinical studies
    • Gergely, P. et al. The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies. Br. J. Pharmacol. 167, 1035-1047 (2012).
    • (2012) Br. J. Pharmacol , vol.167 , pp. 1035-1047
    • Gergely, P.1
  • 69
    • 84870459692 scopus 로고    scopus 로고
    • Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis
    • Komiya, T. et al. Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis. Clin. Exp. Immunol. 171, 54-62 (2013).
    • (2013) Clin. Exp. Immunol , vol.171 , pp. 54-62
    • Komiya, T.1
  • 70
    • 79955045614 scopus 로고    scopus 로고
    • The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation
    • Piali, L. et al. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation. J. Pharmacol. Exp. Ther. 337, 547-556 (2011).
    • (2011) J. Pharmacol. Exp. Ther , vol.337 , pp. 547-556
    • Piali, L.1
  • 71
    • 84878311049 scopus 로고    scopus 로고
    • Fingolimod therapy for multiple sclerosis
    • Willis, M. A. & Cohen, J. A. Fingolimod therapy for multiple sclerosis. Semin. Neurol. 33, 37-44 (2013).
    • (2013) Semin. Neurol , vol.33 , pp. 37-44
    • Willis, M.A.1    Cohen, J.A.2
  • 72
    • 84873692322 scopus 로고    scopus 로고
    • Fingolimod treatment in multiple sclerosis leads to increased macular volume
    • Nolan, R., Gelfand, J. M. & Green, A. J. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology 80, 139-144 (2013).
    • (2013) Neurology , vol.80 , pp. 139-144
    • Nolan, R.1    Gelfand, J.M.2    Green, A.J.3
  • 73
    • 84866690914 scopus 로고    scopus 로고
    • A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis
    • Quancard, J. et al. A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis. Chem. Biol. 19, 1142-1151 (2012).
    • (2012) Chem. Biol , vol.19 , pp. 1142-1151
    • Quancard, J.1
  • 74
    • 79551674537 scopus 로고    scopus 로고
    • FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
    • Choi, J. W. et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl Acad. Sci. USA 108, 751-756 (2011).
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , pp. 751-756
    • Choi, J.W.1
  • 75
    • 33746365908 scopus 로고    scopus 로고
    • Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo
    • Sanna, M. G. et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nature Chem. Biol. 2, 434-441 (2006).
    • (2006) Nature Chem. Biol , vol.2 , pp. 434-441
    • Sanna, M.G.1
  • 76
    • 80052940381 scopus 로고    scopus 로고
    • Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection
    • Teijaro, J. R. et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146, 980-991 (2011).
    • (2011) Cell , vol.146 , pp. 980-991
    • Teijaro, J.R.1
  • 77
    • 0037739755 scopus 로고    scopus 로고
    • A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
    • Matsuoka, Y., Nagahara, Y., Ikekita, M. & Shinomiya, T. A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br. J. Pharmacol. 138, 1303-1312 (2003).
    • (2003) Br. J. Pharmacol , vol.138 , pp. 1303-1312
    • Matsuoka, Y.1    Nagahara, Y.2    Ikekita, M.3    Shinomiya, T.4
  • 78
    • 38049166147 scopus 로고    scopus 로고
    • FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma
    • Liu, Q. et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 111, 275-284 (2008).
    • (2008) Blood , vol.111 , pp. 275-284
    • Liu, Q.1
  • 79
    • 77954376747 scopus 로고    scopus 로고
    • Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers
    • Roberts, K. G. et al. Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res. 70, 5438-5447 (2010).
    • (2010) Cancer Res , vol.70 , pp. 5438-5447
    • Roberts, K.G.1
  • 80
    • 84862909353 scopus 로고    scopus 로고
    • The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways
    • Wang, Z., Jiang, H., Chen, S., Du, F. & Wang, X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228-243 (2012).
    • (2012) Cell , vol.148 , pp. 228-243
    • Wang, Z.1    Jiang, H.2    Chen, S.3    Du, F.4    Wang, X.5
  • 81
    • 84862907788 scopus 로고    scopus 로고
    • Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase
    • Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227 (2012).
    • (2012) Cell , vol.148 , pp. 213-227
    • Sun, L.1
  • 82
    • 33845865825 scopus 로고    scopus 로고
    • Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment
    • Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Rev. Immunol. 7, 41-51 (2007).
    • (2007) Nature Rev. Immunol , vol.7 , pp. 41-51
    • Yu, H.1    Kortylewski, M.2    Pardoll, D.3
  • 83
    • 38949165127 scopus 로고    scopus 로고
    • Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
    • Ding, B. B. et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 111, 1515-1523 (2008).
    • (2008) Blood , vol.111 , pp. 1515-1523
    • Ding, B.B.1
  • 84
    • 70350500225 scopus 로고    scopus 로고
    • STATs in cancer inflammation and immunity: A leading role for STAT3
    • Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Rev. Cancer 9, 798-809 (2009).
    • (2009) Nature Rev. Cancer , vol.9 , pp. 798-809
    • Yu, H.1    Pardoll, D.2    Jove, R.3
  • 85
    • 0033783522 scopus 로고    scopus 로고
    • Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
    • Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951-961 (2000).
    • (2000) J. Clin. Invest , vol.106 , pp. 951-961
    • Liu, Y.1
  • 86
    • 84866487978 scopus 로고    scopus 로고
    • S1P1 inhibits sprouting angiogenesis during vascular development
    • Shoham, A. B. et al. S1P1 inhibits sprouting angiogenesis during vascular development. Development 139, 3859-3869 (2012).
    • (2012) Development , vol.139 , pp. 3859-3869
    • Shoham, A.B.1
  • 87
    • 84866044722 scopus 로고    scopus 로고
    • The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2
    • Gaengel, K. et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev. Cell 23, 587-599 (2012).
    • (2012) Dev. Cell , vol.23 , pp. 587-599
    • Gaengel, K.1
  • 88
    • 84866025219 scopus 로고    scopus 로고
    • Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development
    • Jung, B. et al. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev. Cell 23, 600-610 (2012).
    • (2012) Dev. Cell , vol.23 , pp. 600-610
    • Jung, B.1
  • 89
    • 63649143900 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
    • Ishii, M. et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524-528 (2009).
    • (2009) Nature , vol.458 , pp. 524-528
    • Ishii, M.1
  • 90
    • 78650413566 scopus 로고    scopus 로고
    • Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
    • Ishii, M., Kikuta, J., Shimazu, Y., Meier-Schellersheim, M. & Germain, R. N. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J. Exp. Med. 207, 2793-2798 (2010).
    • (2010) J. Exp. Med , vol.207 , pp. 2793-2798
    • Ishii, M.1    Kikuta, J.2    Shimazu, Y.3    Meier-Schellersheim, M.4    Germain, R.N.5
  • 91
    • 84876864069 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D
    • Kikuta, J. et al. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc. Natl Acad. Sci. USA 110, 7009-7013 (2013).
    • (2013) Proc. Natl Acad. Sci. USA , vol.110 , pp. 7009-7013
    • Kikuta, J.1
  • 92
    • 78149277336 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells
    • Long, J. S. et al. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J. Biol. Chem. 285, 35957-35966 (2010).
    • (2010) J. Biol. Chem , vol.285 , pp. 35957-35966
    • Long, J.S.1
  • 93
    • 84865987259 scopus 로고    scopus 로고
    • Selectivity and specificity of sphingosine-1-phosphate receptor ligands: Caveats and critical thinking in characterizing receptor-mediated effects
    • Salomone, S. & Waeber, C. Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. Front. Pharmacol. 2, 9 (2011).
    • (2011) Front. Pharmacol , vol.2 , pp. 9
    • Salomone, S.1    Waeber, C.2
  • 94
    • 33646117016 scopus 로고    scopus 로고
    • Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: The role of sphingosine kinase-1
    • Sukocheva, O. et al. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J. Cell Biol. 173, 301-310 (2006).
    • (2006) J. Cell Biol , vol.173 , pp. 301-310
    • Sukocheva, O.1
  • 95
    • 78149348826 scopus 로고    scopus 로고
    • High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients
    • Watson, C. et al. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. Am. J. Pathol. 177, 2205-2215 (2010).
    • (2010) Am. J. Pathol , vol.177 , pp. 2205-2215
    • Watson, C.1
  • 96
    • 84859363534 scopus 로고    scopus 로고
    • In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody
    • Harris, G. L., Creason, M. B., Brulte, G. B. & Herr, D. R. In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody. PLoS ONE 7, e35129 (2012).
    • (2012) PLoS ONE , vol.7
    • Harris, G.L.1    Creason, M.B.2    Brulte, G.B.3    Herr, D.R.4
  • 97
    • 77952327561 scopus 로고    scopus 로고
    • Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung
    • Sammani, S. et al. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am. J. Respir. Cell. Mol. Biol. 43, 394-402 (2010).
    • (2010) Am. J. Respir. Cell. Mol. Biol , vol.43 , pp. 394-402
    • Sammani, S.1
  • 98
    • 41649094810 scopus 로고    scopus 로고
    • Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation
    • Niessen, F. et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452, 654-658 (2008).
    • (2008) Nature , vol.452 , pp. 654-658
    • Niessen, F.1
  • 99
    • 84868328440 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury
    • Sun, X. et al. Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. Am. J. Respir. Cell. Mol. Biol. 47, 628-636 (2012).
    • (2012) Am. J. Respir. Cell. Mol. Biol , vol.47 , pp. 628-636
    • Sun, X.1
  • 100
    • 80355129639 scopus 로고    scopus 로고
    • Sphingosine-1-phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model
    • Schulze, T. et al. Sphingosine-1-phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J. 25, 4024-4036 (2011).
    • (2011) FASEB J , vol.25 , pp. 4024-4036
    • Schulze, T.1
  • 101
    • 79953190058 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking
    • Allende, M. L. et al. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. J. Biol. Chem. 286, 7348-7358 (2011).
    • (2011) J. Biol. Chem , vol.286 , pp. 7348-7358
    • Allende, M.L.1
  • 102
    • 80051924460 scopus 로고    scopus 로고
    • SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor
    • Urbano, M. et al. SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor. Bioorg. Med. Chem. Lett. 21, 5470-5474 (2011).
    • (2011) Bioorg. Med. Chem. Lett , vol.21 , pp. 5470-5474
    • Urbano, M.1
  • 103
    • 70449732610 scopus 로고    scopus 로고
    • T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow
    • Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
    • (2009) J. Exp. Med , vol.206 , pp. 2469-2481
    • Jenne, C.N.1
  • 104
    • 77957660978 scopus 로고    scopus 로고
    • Design and synthesis of selective and potent orally active S1P5 agonists
    • Mattes, H. et al. Design and synthesis of selective and potent orally active S1P5 agonists. ChemMedChem 5, 1693-1696 (2010).
    • (2010) ChemMedChem , vol.5 , pp. 1693-1696
    • Mattes, H.1
  • 105
    • 84879172983 scopus 로고    scopus 로고
    • Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis
    • Yang, L. et al. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. J. Hepatol. 59, 114-123 (2013).
    • (2013) J. Hepatol , vol.59 , pp. 114-123
    • Yang, L.1
  • 106
    • 70149120314 scopus 로고    scopus 로고
    • Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts
    • Kapitonov, D. et al. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res. 69, 6915-6923 (2009).
    • (2009) Cancer Res , vol.69 , pp. 6915-6923
    • Kapitonov, D.1
  • 107
    • 84873409675 scopus 로고    scopus 로고
    • A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent mouse model of allergic asthma
    • Price, M. M. et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent mouse model of allergic asthma. J. Allergy Clin. Immunol. 131, 501-511 (2012).
    • (2012) J. Allergy Clin. Immunol , vol.131 , pp. 501-511
    • Price, M.M.1
  • 108
    • 79954625512 scopus 로고    scopus 로고
    • A phase i clinical trial of safingol in combination with cisplatin in advanced solid tumors
    • Dickson, M. A. et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. Clin. Cancer Res. 17, 2484-2492 (2011).
    • (2011) Clin. Cancer Res , vol.17 , pp. 2484-2492
    • Dickson, M.A.1
  • 109
    • 84874670502 scopus 로고    scopus 로고
    • Characterization of isoenzyme-selective inhibitors of human sphingosine kinases
    • Gao, P., Peterson, Y. K., Smith, R. A. & Smith, C. D. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases. PLoS ONE 7, e44543 (2012).
    • (2012) PLoS ONE , vol.7
    • Gao, P.1    Peterson, Y.K.2    Smith, R.A.3    Smith, C.D.4
  • 110
    • 79959498910 scopus 로고    scopus 로고
    • Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
    • Antoon, J. W. et al. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. J. Mol. Endocrinol. 46, 205-216 (2011).
    • (2011) J. Mol. Endocrinol , vol.46 , pp. 205-216
    • Antoon, J.W.1
  • 111
    • 84864371831 scopus 로고    scopus 로고
    • Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats
    • Liu, Q. et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. PLoS ONE 7, e41834 (2012).
    • (2012) PLoS ONE , vol.7
    • Liu, Q.1
  • 112
    • 79960731365 scopus 로고    scopus 로고
    • S1P is associated with protection in human and experimental cerebral malaria
    • Finney, C. A. et al. S1P is associated with protection in human and experimental cerebral malaria. Mol. Med. 17, 717-725 (2011).
    • (2011) Mol. Med , vol.17 , pp. 717-725
    • Finney, C.A.1
  • 113
    • 79955485953 scopus 로고    scopus 로고
    • STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma
    • Scuto, A. et al. STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res. 71, 3182-3188 (2011).
    • (2011) Cancer Res , vol.71 , pp. 3182-3188
    • Scuto, A.1
  • 114
    • 84871968824 scopus 로고    scopus 로고
    • Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
    • Saddoughi, S. A. et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol. Med. 5, 105-121 (2013).
    • (2013) EMBO Mol. Med , vol.5 , pp. 105-121
    • Saddoughi, S.A.1
  • 115
    • 19944432761 scopus 로고    scopus 로고
    • KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts
    • Shimizu, H. et al. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation 111, 222-229 (2005).
    • (2005) Circulation , vol.111 , pp. 222-229
    • Shimizu, H.1
  • 116
    • 33344462470 scopus 로고    scopus 로고
    • Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model
    • Suzuki, C. et al. Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model. J. Heart Lung Transplant. 25, 302-309 (2006).
    • (2006) J. Heart Lung Transplant , vol.25 , pp. 302-309
    • Suzuki, C.1
  • 117
    • 37349056751 scopus 로고    scopus 로고
    • A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice
    • Song, J. et al. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice. J. Pharmacol. Exp. Ther. 324, 276-283 (2008).
    • (2008) J. Pharmacol. Exp. Ther , vol.324 , pp. 276-283
    • Song, J.1
  • 118
    • 55249113624 scopus 로고    scopus 로고
    • Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist
    • Wenderfer, S. E., Stepkowski, S. M. & Braun, M. C. Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int. 74, 1319-1326 (2008).
    • (2008) Kidney Int , vol.74 , pp. 1319-1326
    • Wenderfer, S.E.1    Stepkowski, S.M.2    Braun, M.C.3
  • 119
    • 84862509411 scopus 로고    scopus 로고
    • Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R/) mice
    • Poti, F. et al. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R/) mice. Vascul. Pharmacol. 57, 56-64 (2012).
    • (2012) Vascul. Pharmacol , vol.57 , pp. 56-64
    • Poti, F.1
  • 120
    • 71749087668 scopus 로고    scopus 로고
    • AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis
    • Zhang, Z. Y. et al. AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis. J. Neuroimmunol. 216, 59-65 (2009).
    • (2009) J. Neuroimmunol , vol.216 , pp. 59-65
    • Zhang, Z.Y.1
  • 121
    • 84866559134 scopus 로고    scopus 로고
    • A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner
    • Galicia-Rosas, G. et al. A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner. J. Immunol. 189, 3700-3706 (2012).
    • (2012) J. Immunol , vol.189 , pp. 3700-3706
    • Galicia-Rosas, G.1
  • 122
    • 33646525690 scopus 로고    scopus 로고
    • S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure
    • Lien, Y. H., Yong, K. C., Cho, C., Igarashi, S. & Lai, L. W. S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int. 69, 1601-1608 (2006).
    • (2006) Kidney Int , vol.69 , pp. 1601-1608
    • Lien, Y.H.1    Yong, K.C.2    Cho, C.3    Igarashi, S.4    Lai, L.W.5
  • 123
    • 79955596917 scopus 로고    scopus 로고
    • Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes
    • Awad, A. S. et al. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 79, 1090-1098 (2011).
    • (2011) Kidney Int , vol.79 , pp. 1090-1098
    • Awad, A.S.1
  • 124
    • 24944535833 scopus 로고    scopus 로고
    • S1P1-selective in vivo-active agonists from high-throughput screening: Off-The-shelf chemical probes of receptor interactions, signaling, and fate
    • Jo, E. et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12, 703-715 (2005).
    • (2005) Chem. Biol , vol.12 , pp. 703-715
    • Jo, E.1
  • 125
    • 79956068785 scopus 로고    scopus 로고
    • Discovery of CS-0777: A potent, selective, and orally active S1P1 agonist
    • Nishi, T. et al. Discovery of CS-0777: a potent, selective, and orally active S1P1 agonist. ACS Med. Chem. Lett. 2, 368-372 (2011).
    • (2011) ACS Med. Chem. Lett , vol.2 , pp. 368-372
    • Nishi, T.1
  • 126
    • 60849108052 scopus 로고    scopus 로고
    • A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection
    • Marsolais, D. et al. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc. Natl Acad. Sci. USA 106, 1560-1565 (2009).
    • (2009) Proc. Natl Acad. Sci. USA , vol.106 , pp. 1560-1565
    • Marsolais, D.1
  • 127
    • 84855366097 scopus 로고    scopus 로고
    • Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities
    • Fujii, Y. et al. Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities. J. Immunol. 188, 206-215 (2012).
    • (2012) J. Immunol , vol.188 , pp. 206-215
    • Fujii, Y.1
  • 128
    • 54349121551 scopus 로고    scopus 로고
    • Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-Like headgroup interactions
    • Gonzalez-Cabrera, P. J. et al. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-Like headgroup interactions. Mol. Pharmacol. 74, 1308-1318 (2008).
    • (2008) Mol. Pharmacol , vol.74 , pp. 1308-1318
    • Gonzalez-Cabrera, P.J.1
  • 129
    • 15444373345 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate analogs as receptor antagonists
    • Davis, M. D., Clemens, J. J., Macdonald, T. L. & Lynch, K. R. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 280, 9633-9641 (2005).
    • (2005) J. Biol. Chem , vol.280 , pp. 9633-9641
    • Davis, M.D.1    Clemens, J.J.2    MacDonald, T.L.3    Lynch, K.R.4
  • 130
    • 80054988629 scopus 로고    scopus 로고
    • The sphingosine-1-phosphate receptor-1 antagonist W146, causes early and short-lasting peripheral blood lymphopenia in mice
    • Tarrason, G. et al. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice. Int. Immunopharmacol. 11, 1773-1779 (2011).
    • (2011) Int. Immunopharmacol , vol.11 , pp. 1773-1779
    • Tarrason, G.1
  • 131
    • 84872867676 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism
    • Finley, A. et al. Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. PLoS ONE 8, e55255 (2013).
    • (2013) PLoS ONE , vol.8
    • Finley, A.1
  • 132
    • 84875723927 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: Assessment of expression and role in cell migration
    • Kluk, M. J. et al. Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration. Lab. Invest. 93, 462-471 (2013).
    • (2013) Lab. Invest , vol.93 , pp. 462-471
    • Kluk, M.J.1
  • 133
    • 33845296479 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists
    • Foss, F. W. Jr et al. Synthesis and biological evaluation of-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg. Med. Chem. 15, 663-677 (2007).
    • (2007) Bioorg. Med. Chem , vol.15 , pp. 663-677
    • Foss Jr., F.W.1
  • 134
    • 78650866759 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis
    • Skoura, A. et al. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 81-85 (2011).
    • (2011) Arterioscler. Thromb. Vasc. Biol , vol.31 , pp. 81-85
    • Skoura, A.1
  • 135
    • 0037310755 scopus 로고    scopus 로고
    • Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5
    • Ikeda, H. et al. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology 124, 459-469 (2003).
    • (2003) Gastroenterology , vol.124 , pp. 459-469
    • Ikeda, H.1
  • 136
    • 77952693294 scopus 로고    scopus 로고
    • 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists
    • Bolli, M. H. et al. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. J. Med. Chem. 53, 4198-4211 (2010).
    • (2010) J. Med. Chem , vol.53 , pp. 4198-4211
    • Bolli, M.H.1
  • 137
    • 33644830810 scopus 로고    scopus 로고
    • Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
    • Visentin, B. et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9, 225-238 (2006).
    • (2006) Cancer Cell , vol.9 , pp. 225-238
    • Visentin, B.1
  • 138
    • 84888281434 scopus 로고    scopus 로고
    • Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization
    • Caballero, S. et al. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp. Eye Res. (2008).
    • (2008) Exp. Eye Res.
    • Caballero, S.1
  • 139
    • 80052542781 scopus 로고    scopus 로고
    • Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis
    • Sanada, Y. et al. Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS ONE 6, e23933 (2011).
    • (2011) PLoS ONE , vol.6
    • Sanada, Y.1
  • 140
    • 4444316123 scopus 로고    scopus 로고
    • Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: Discovery of potent, subtype-selective S1P4 receptor agonists
    • Clemens, J. J., Davis, M. D., Lynch, K. R. & Macdonald, T. L. Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. Bioorg. Med. Chem. Lett. 14, 4903-4906 (2004).
    • (2004) Bioorg. Med. Chem. Lett , vol.14 , pp. 4903-4906
    • Clemens, J.J.1    Davis, M.D.2    Lynch, K.R.3    MacDonald, T.L.4
  • 141
    • 85016365810 scopus 로고    scopus 로고
    • S1P4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs
    • Ota, H. et al. S1P4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs. Pulm. Circ. 1, 399-404 (2011).
    • (2011) Pulm. Circ , vol.1 , pp. 399-404
    • Ota, H.1
  • 142
    • 84856516517 scopus 로고    scopus 로고
    • Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation
    • Song, J., Hagiya, H., Kurata, H., Mizuno, H. & Ito, T. Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation. Transpl. Immunol. 26, 163-170 (2012).
    • (2012) Transpl. Immunol , vol.26 , pp. 163-170
    • Song, J.1    Hagiya, H.2    Kurata, H.3    Mizuno, H.4    Ito, T.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.